Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 2021

View Archived Issues

New phase II/III study evaluates BLU-263 in patients with indolent systemic mastocytosis

Mechanism identified for HBsAg reduction with Aligos Therapeutics STOPS molecule ALG-10000

Newly identified lncRNA could be a biomarker of liver and pancreatic cancers

Morehouse School of Medicine Chlamydia vaccine VCG-Pmp18.3 is protective in vivo

Positive phase I data for AKS-452, a protein subunit COVID-19 vaccine candidate

Crinetics Pharmaceuticals synthesizes melanocortin MC2 receptor antagonists

Landos Biopharma patents new LANCL2 activators

U.S. Department of Health & Human Services divulges compounds for HIV infection

Janssen Pharmaceutica discloses new OGA inhibitors

Genentech patents anti-LY6G6D antibodies for colorectal cancer

Evaxion presents phase I/IIa data for its cancer immunotherapy candidates, EVX-01 and EVX-02

Study casts further light on cancer immunotherapy

Discovery, optimization and in vivo evaluation of novel tetrahydropyran-based galectin-3 inhibitors

Results of two trials of chemoattenuated PfSPZ vaccines in controlled human malaria infections

EDP-721, a novel HBV RNA destabilizer with promising preclinical efficacy

HDAC6 inhibitors improve LVEF in murine model of DCM

YH-34160 leads to potent and sustained body weight loss in DIO mouse model

Bioasis reports outcome of preclinical study of xB3-IL-1RA for MS

FDA clears eIND for 68Ga-RMX-VH in glioblastoma multiforme

Biomarker panel identifies cardiovascular risk and benefit from SGLT2 inhibitors

Novel SARS-CoV-2 inactivated vaccine induces robust immune responses in healthy adults

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...